Dana Orange

Dana Orange

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2023 in Nature
Verified
Journal Article
Open access
PDF file
FZFan Zhang
Fan Zhang
AJAnna Helena Jonsson
Anna Helena Jonsson
ANAparna Nathan
Aparna Nathan
NMNghia Millard
Nghia Millard
MCMichelle Curtis
Michelle Curtis
ZZZhu Zhu
Zhu Zhu
Rheumatoid arthritis is a prototypical autoimmune disease that causes joint inflammation and destruction1. There is currently no cure for rheumatoid arthritis, and the effectiveness of treatments varies across patients, suggesting an undefined pathogenic diversity1,2. Here, to deconstruct the cell states and pathways that characterize this pathogenic heterogeneity, we profiled the full spectrum of cells in inflamed synovium from patients with rheumatoid arthritis. We used multi-modal single-cell RNA-sequencing and surface protein data coupled with histology of synovial tissue from 79 donors to build single-cell atlas of rheumatoid arthritis synovial tissue that includes more than 314,000 cells. We stratified tissues into six groups, referred to as cell-type abundance phenotypes (CTAPs), each characterized by selectively enriched cell states. These CTAPs demonstrate the diversity of synovial inflammation in rheumatoid arthritis, ranging from samples enriched for T and B cells to those largely lacking lymphocytes. Disease-relevant cell states, cytokines, risk genes, histology and serology metrics are associated with particular CTAPs. CTAPs are dynamic and can predict treatment response, highlighting the clinical utility of classifying rheumatoid arthritis synovial phenotypes. This comprehensive atlas and molecular, tissue-based stratification of rheumatoid arthritis synovial tissue reveal new insights into rheumatoid arthritis pathology and heterogeneity that could inform novel targeted treatments.

22 February 2018 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
DODana Orange
Dana Orange
PAPhaedra Agius
Phaedra Agius
EDEdward F. DiCarlo
Edward F. DiCarlo
NRNicolas Robine
Nicolas Robine
HGHeather Geiger
Heather Geiger
LDLaura Donlin
Laura Donlin

16 July 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
DODana Orange
Dana Orange
VYVicky Yao
Vicky Yao
KSKirsty Sawicka
Kirsty Sawicka
JFJohn Fak
John Fak
MFMayu O. Frank
Mayu O. Frank
RDRobert B. Darnell
Robert B. Darnell
Rheumatoid arthritis, like many inflammatory diseases, is characterized by episodes of quiescence and exacerbation (flares). The molecular events leading to flares are unknown.

22 February 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
RBR. Camille Brewer
R. Camille Brewer
TLTobias Lanz
Tobias Lanz
CHCaryn R. Hale
Caryn R. Hale
GSGregory D. Sepich-Poore
Gregory D. Sepich-Poore
CMCameron Martino
Cameron Martino
DODana Orange
Dana Orange
Periodontal disease is more common in individuals with rheumatoid arthritis (RA) who have detectable anti-citrullinated protein antibodies (ACPAs), implicating oral mucosal inflammation in RA pathogenesis. Here, we performed paired analysis of human and bacterial transcriptomics in longitudinal blood samples from RA patients. We found that patients with RA and periodontal disease experienced repeated oral bacteremias associated with transcriptional signatures of ISG15 + HLADR hi and CD48 high S100A2 pos monocytes, recently identified in inflamed RA synovia and blood of those with RA flares. The oral bacteria observed transiently in blood were broadly citrullinated in the mouth, and their in situ citrullinated epitopes were targeted by extensively somatically hypermutated ACPAs encoded by RA blood plasmablasts. Together, these results suggest that (i) periodontal disease results in repeated breaches of the oral mucosa that release citrullinated oral bacteria into circulation, which (ii) activate inflammatory monocyte subsets that are observed in inflamed RA synovia and blood of RA patients with flares and (iii) activate ACPA B cells, thereby promoting affinity maturation and epitope spreading to citrullinated human antigens.

12 November 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
SYShady Younis
Shady Younis
SMSalvinaz Islam Moutusy
Salvinaz Islam Moutusy
SRSajede Rasouli
Sajede Rasouli
SJShaghayegh Jahanbani
Shaghayegh Jahanbani
MPMahesh Pandit
Mahesh Pandit
WRWilliam H. Robinson
William H. Robinson
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by antinuclear antibodies (ANAs). Epstein-Barr virus (EBV) infection has been epidemiologically associated with SLE, yet its role in pathogenesis remains incompletely defined. Here, we developed an EBV-specific single-cell RNA-sequencing platform and used it to demonstrate that EBV infection reprograms autoreactive antinuclear antigen B cells to drive autoimmunity in SLE. We demonstrated that, in SLE, EBV + B cells are predominantly CD27 + CD21 low memory B cells that are present at increased frequencies and express ZEB2 , TBX21 (T-bet), and antigen-presenting cell transcriptional pathways. Integrative analysis of chromatin immunoprecipitation sequencing (ChIP-seq), assay for transposase-accessible chromatin sequencing (ATAC-seq), and RNA polymerase II occupancy data revealed EBV nuclear antigen 2 (EBNA2) binding at the transcriptional start sites and regulatory regions of CD27 , ZEB2 , and TBX21 , as well as the antigen-presenting cell genes demonstrated to be up-regulated in SLE EBV + B cells. We expressed recombinant antibodies from SLE EBV + B cells and demonstrated that they bind prototypical SLE nuclear autoantigens, whereas those from healthy individuals do not. We further found that SLE EBV + B cells can serve as antigen-presenting cells to drive activation of T peripheral helper cells with concomitant activation of related EBV − antinuclear double-negative 2 B cells and plasmablasts. Our results provide a mechanistic basis for EBV being a driver of SLE through infecting and reprogramming nuclear antigen-reactive B cells to become activated antigen-presenting cells with the potential to promote systemic disease–driving autoimmune responses.

10 April 2024 in Science Translational Medicine
Verified
Journal Article
Closed access
ZBZilong Bai
Zilong Bai
NBNicholas Bartelo
Nicholas Bartelo
MAMaryam Aslam
Maryam Aslam
EMElisabeth A. Murphy
Elisabeth A. Murphy
CHCaryn R. Hale
Caryn R. Hale
KWKevin Wei
Kevin Wei
It has been presumed that rheumatoid arthritis (RA) joint pain is related to inflammation in the synovium; however, recent studies reveal that pain scores in patients do not correlate with synovial inflammation. We developed a machine-learning approach (graph-based gene expression module identification or GbGMI) to identify an 815-gene expression module associated with pain in synovial biopsy samples from patients with established RA who had limited synovial inflammation at arthroplasty. We then validated this finding in an independent cohort of synovial biopsy samples from patients who had early untreated RA with little inflammation. Single-cell RNA sequencing analyses indicated that most of these 815 genes were most robustly expressed by lining layer synovial fibroblasts. Receptor-ligand interaction analysis predicted cross-talk between human lining layer fibroblasts and human dorsal root ganglion neurons expressing calcitonin gene–related peptide (CGRP + ). Both RA synovial fibroblast culture supernatant and netrin-4, which is abundantly expressed by lining fibroblasts and was within the GbGMI-identified pain-associated gene module, increased the branching of pain-sensitive murine CGRP + dorsal root ganglion neurons in vitro. Imaging of solvent-cleared synovial tissue with little inflammation from humans with RA revealed CGRP + pain-sensing neurons encasing blood vessels growing into synovial hypertrophic papilla. Together, these findings support a model whereby synovial lining fibroblasts express genes associated with pain that enhance the growth of pain-sensing neurons into regions of synovial hypertrophy in RA.